Growing community of inventors

Marloffstein, Germany

Alexander Steinkasserer

Average Co-Inventor Count = 3.11

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Alexander SteinkassererMatthias Lechmann (6 patents)Alexander SteinkassererElisabeth Zinser (5 patents)Alexander SteinkassererThomas Werner (1 patent)Alexander SteinkassererMarcello Stein (1 patent)Alexander SteinkassererElizabeth Zinser (1 patent)Alexander SteinkassererIlka Knippertz (1 patent)Alexander SteinkassererThomas Werner (0 patent)Alexander SteinkassererDmytro Royzman (0 patent)Alexander SteinkassererAlexander Steinkasserer (7 patents)Matthias LechmannMatthias Lechmann (6 patents)Elisabeth ZinserElisabeth Zinser (5 patents)Thomas WernerThomas Werner (17 patents)Marcello SteinMarcello Stein (1 patent)Elizabeth ZinserElizabeth Zinser (1 patent)Ilka KnippertzIlka Knippertz (1 patent)Thomas WernerThomas Werner (0 patent)Dmytro RoyzmanDmytro Royzman (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Argos Therapeutics, Inc. (5 from 40 patents)

2. Other (1 from 832,812 patents)

3. Friedrich-alexander-univeristät Erlangen-nürnberg (1 from 1 patent)

4. Friedrich-alexander-universitat Erlangen-nürnberg (53 patents)


7 patents:

1. 9822377 - Mutant CD83 promoter and use thereof

2. 9732140 - Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

3. 9102726 - Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same

4. 8759505 - Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

5. 8124099 - Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

6. 7893200 - Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

7. 7169898 - Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/20/2025
Loading…